Louis M. Weiner
Affiliations: | Tumor Biology | Georgetown University, Washington, DC |
Area:
Cell Biology, Immunology, Molecular BiologyGoogle:
"Louis Weiner"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fitzgerald AA, Wang S, Agarwal V, et al. (2021) DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma. Journal For Immunotherapy of Cancer. 9 |
| Davis-Marcisak EF, Fitzgerald AA, Kessler MD, et al. (2021) Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors. Genome Medicine. 13: 129 |
| Ajina R, Malchiodi ZX, Fitzgerald AA, et al. (2021) Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance. Cancer Immunology Research |
| Malchiodi ZX, Weiner LM. (2021) Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal Adenocarcinoma. Cancers. 13 |
| Ajina R, Weiner LM. (2020) T-Cell Immunity in Pancreatic Cancer. Pancreas. 49: 1014-1023 |
| Zahavi D, Weiner L. (2020) Monoclonal Antibodies in Cancer Therapy. Antibodies (Basel, Switzerland). 9 |
| Pishvaian MJ, Wang H, He AR, et al. (2020) A Phase I/II Study of Veliparib (ABT-888) in combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Fitzgerald AA, Weiner LM. (2020) The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Reviews |
| Zhang YW, Nasto RE, Jablonski SA, et al. (2020) RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attack. Methods in Enzymology. 636: 299-322 |
| Wang S, Fitzgerald A, Ajina R, et al. (2020) Abstract 6636: Therapy with BXCL701 (B), a DPP8, DPP9, DPPIV and FAP inhibitor, in combination with anti-PD1 antibody (PD1) in a syngeneic murine pancreatic ductal adenocarcinoma (PDAC) model improves treatment outcomes and induces intratumoral NK cell infiltrates and a marked reduction in tumor stromal fibrosis Immunology |